The effect of a combination of medetomidine-butorphanol and medetomidine, butorphanol, atropine on glomerular filtration rate in dogs

Veterinary Radiology and Ultrasound

Volumn 42, Issue 5, 2001, Pages 458-462

  Grimm, Jennifer B ^a   Grimm, Kurt A ^a   Kneller, Stephen K ^a   Tranquilli, William J ^a   Crochik, Sonia S ^a   Bischoff, Matthew G ^a   Podolski, Jennifer L ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Dogs; Glomerular filtration rate; Medetomidine; Nuclear scintigraphy; Renal physiology

Indexed keywords

CANIS FAMILIARIS;

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATROPINE; BUTORPHANOL; DIAGNOSTIC AGENT; HYPNOTIC SEDATIVE AGENT; MEDETOMIDINE; PENTETATE TECHNETIUM TC 99M;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD PRESSURE; DOG; DRUG COMBINATION; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HEART RATE; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY; MALE; PHYSIOLOGY; RANDOMIZATION; SCINTISCANNING; TIME;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ATROPINE; BLOOD PRESSURE; BUTORPHANOL; DOGS; DRUG THERAPY, COMBINATION; GLOMERULAR FILTRATION RATE; HEART RATE; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAMUSCULAR; KIDNEY; MALE; MEDETOMIDINE; RANDOM ALLOCATION; TECHNETIUM TC 99M PENTETATE; TIME FACTORS;

EID: 0035458713     PISSN: 10588183     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2001.tb00970.x     Document Type: Article

References (29)

1. Guyton AC. Textbook of Medical Physiology. 9th ed. Philadelphia: W.B. Saunders Company, 1996:315-330.
2. Klopper JF, Hauser W, Atkins HL, et al. Evaluation of 99m Tc-DTPA for the measurement of glomerular filtration rate. J Nucl Med 1972; 13:107-110.
3. Moe L, Heiene R. Estimation of glomerular filtration rate in dogs with 99M-Tc-DTPA and iohexol. Res Vet Sci 1995;58:138-143.
4. Seldin DW, Giebisch G. The Kidney: Physiology and Pathophysiology. New York: Raven Press, 1985;397-497.
5. Gates GF. Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). Am J Roentgenol 1982;138: 565-570.
6. Barbour GL, Crumb CK, Boyd CM, et al. Comparison of inulin, iothalamate, and 99mTc-DTPA for measurement of glomerular filtration rate. J Nucl Med 1976;17:317-320.
7. Powers TA, Stone WJ, Grove RB, et al. Radionuclide measurement of differential glomerular filtration rate. Invest Radiol 1981;16:59-64.
8. Daniel GB, Mitchell SK, Mawby D, et al. Renal nuclear medicine: a review. Vet Radiol Ultrasound 1999;40:572-587.
9. Krawiec DR, Badertscher RR, Twardock AR, et al. Evaluation of 99mTc-diethylenetriaminepentaacetic acid nuclear imaging for quantitative determination of the glomerular filtration rate of dogs. Am J Vet Res 1986;47:2175-2179.
10. Krawiec DR, Twardock AR, Badertscher RR, et al. Use of 99mTc diethylenetriaminepentaacetic acid for assessment of renal function in dogs with suspected renal disease. J Am Vet Med Assoc 1988;192:1077-1080.
11. Uribe D, Krawiec DR, Twardock AR, et al. Quantitative renal scintigraphic determination of the glomerular filtration rate in cats with normal and abnormal kidney function, using 99mTc-diethylenetriaminepentaacetic acid. Am J Vet Res 1992;53:1101-1107.
12. Ko JC, Bailey JE, Pablo LS, et al. Comparison of sedative and cardiorespiratory effects of medetomidine and medetomidine-butorphanol combination in dogs. Am J Vet Res 1996;57:535-540.
13. Paddleford RR, Harvey RC. Alpha 2 agonists and antagonists. Vet Clim North Am Small Anim Pract 1999;29:737-745.
14. Pypendop BH, Verstegen JP. Hemodynamic effects of medetomidine in the dog: a dose titration study. Vet Surg 1998;27:612-622.
15. Vainio O. Introduction to the clinical pharmacology of medetomidine. Acta Vet Scand Suppl 1989;85:85-88.
16. Alibhai HI, Clarke KW, Lee YH, et al. Cardiopulmonary effects of combinations of medetomidine hydrochloride and atropine sulphate in dogs. Vet Rec 1996;138:11-13.
17. Autran de Morais HS, Muir WW. The effects of medetomidine on cardiac contractility in autonomically blocked dogs. Vet Surg 1995;24: 356-364.
18. Vainio O, Palmu L. Cardiovascular and respiratory effects of medetomidine in dogs and influence of anticholinergics. Acta Vet Scand 1989;30:401-408.
19. Grimm KA, Thurmon JC, Olson WA, et al. The pharmacodynamics of thiopental, medetomidine, butorphanol and atropine in beagle dogs. J Vet Pharmacol Ther 1998;21:133-137.
20. Newell SM, Ko JC, Ginn PE, et al. Effects of three sedative protocols on glomerular filtration rate in clinically normal dogs. Am J Vet Res 1997;58:446-450.
21. Twardock AR, Krawiec DR, Itkin RJ. Renal Imaging I: Functional Renal Scintigraphy. In: Berry CR, Daniel GB, eds. Handbook of Veterinary Nuclear Medicine. Raleigh: North Carolina State University, 1996;122-130.
22. Muir WW, Mason D. Cardiovascular System. In: Thurmon JC, Tranquilli WJ, Benson GJ, eds. Lumb and Jones' Veterinary Anesthesia. Baltimore: Williams and Wilkens, 1996;62-114.
23. Strandhoy JW. Role of alpha-2 receptors in the regulation of renal function. J Cardiovasc Pharmacol 1985;7(Suppl 8):S28-S33
24. Salonen JS. Pharmacokinetics of medetomidine. Acta Vet Scand Suppl 1989;85:49-54.
25. Simon F, Romvary A, Mora S. Clinical investigations of medetomidine in dogs. Acta Vet Scand Suppl 1989;85:161-165.
26. Cullen LK. Medetomidine sedation in dogs and cats: a review of its pharmacology, antagonism and dose. Br Vet J 1996;152:519-535.
27. Strandhoy JW, Morris M, Buckalew VMJ. Renal effects of the antihypertensive, guanabenz, in the dog. J Pharmacol Exp Ther 1982;221: 347-352.
28. Trim CM. Cardiopulmonary effects of butorphanol tartrate in dogs. Am J Vet Res 1983;44:329-331.
29. Osborne CA, Finco DR. Canine and Feline Nephrology and Urology. Baltimore: Williams & Wilkins, 1995;335-367.